ATARA BIOTHERAPEUTICS, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ATARA BIOTHERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2019-09-30 was $160.00K, a 95.64% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2019-06-30 was $1.80M, a 79.19% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2019-03-31 was $2.90M, a 53.23% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2018-09-30 was $3.67M.
- ATARA BIOTHERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2018 was $24.69M, a 1362.74% increase from fiscal 2017.
- ATARA BIOTHERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2017 was $1.69M, a 181.33% increase from fiscal 2016.
- ATARA BIOTHERAPEUTICS, INC. stock issued during period, value, employee stock purchase plan for fiscal 2016 was $600.00K.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2019-09-30 | $160.00K 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $1.80M 10-Q · filed 2019-11-07 | |
| 2019-03-31 | $2.90M 10-Q · filed 2019-11-07 | |
| 2018-12-31 | $24.69M 10-K · filed 2019-02-26 | |
| 2018-09-30 | $3.67M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $8.66M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $6.20M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $1.69M 10-K · filed 2019-02-26 | |
| 2016-12-31 | $600.00K 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |